These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Plasma catecholamines during behavioral treatments for Raynaud's disease. Freedman RR; Keegan D; Migály P; Galloway MP; Mayes M Psychosom Med; 1991; 53(4):433-9. PubMed ID: 1924655 [TBL] [Abstract][Full Text] [Related]
5. Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon. Graafsma SJ; Wollersheim H; Droste HT; ten Dam MA; van Tits LJ; Reyenga J; Rodrigues de Miranda JF; Thien T Clin Sci (Lond); 1991 Apr; 80(4):325-31. PubMed ID: 1851068 [TBL] [Abstract][Full Text] [Related]
6. Studies of endogenous catecholamines in patients with Raynaud's phenomenon secondary to progressive systemic sclerosis (scleroderma). Sapira JD; Rodnan GP; Scheib ET; Klaniecki T; Rizk M Am J Med; 1972 Mar; 52(3):330-7. PubMed ID: 4551793 [No Abstract] [Full Text] [Related]
7. Effect of reserpine in Raynaud's phenomenon. Kontos HA; Wasserman AJ Circulation; 1969 Feb; 39(2):259-66. PubMed ID: 5763842 [No Abstract] [Full Text] [Related]
8. Neuroendocrine response to cold in Raynaud's syndrome. Surwit RS; Allen LM; Gilgor RS; Schanberg S; Kuhn C; Duvic M Life Sci; 1983 Feb; 32(9):995-1000. PubMed ID: 6600810 [TBL] [Abstract][Full Text] [Related]
9. Vascular and humoral sympathetic nervous system reactivity during mental arithmetic in primary Raynaud's phenomenon. Droste H; Wollersheim H; Reyenga J; Thien T Int Angiol; 1990; 9(2):84-9. PubMed ID: 2254680 [TBL] [Abstract][Full Text] [Related]
10. Pheochromocytoma in a patient with a preliminary diagnosis of Raynaud's phenomenon. Keles Z; Onur O; Carlioglu A; Sarifakioglu E Scand J Rheumatol; 2010 Nov; 39(6):523-4. PubMed ID: 20858141 [No Abstract] [Full Text] [Related]
11. Abnormal platelet aggregation in patients with Raynaud's phenomenon. Biondi ML; Marasini B J Clin Pathol; 1989 Jul; 42(7):716-8. PubMed ID: 2760232 [TBL] [Abstract][Full Text] [Related]
12. Effect of magnesium sulfate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud's phenomenon. Leppert J; Myrdal U; Hedner T; Edvinsson L; Tracz Z; Ringqvist I Angiology; 1994 Jul; 45(7):637-45. PubMed ID: 8024163 [TBL] [Abstract][Full Text] [Related]
13. [On the role of the sympathetic nervous system in the pathogenesis of Raynaud's phenomenon following the use of vibrating instruments. 3. Behavior of endogenous neracrenaline]. Spinazzola A; Nissardi GP; Zedda S Boll Soc Ital Biol Sper; 1968 Apr; 44(7):681-3. PubMed ID: 5672169 [No Abstract] [Full Text] [Related]
18. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Zamora MR; O'Brien RF; Rutherford RB; Weil JV Lancet; 1990 Nov; 336(8724):1144-7. PubMed ID: 1978025 [TBL] [Abstract][Full Text] [Related]
19. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease. Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518 [TBL] [Abstract][Full Text] [Related]
20. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases. Rychlik-Golema W; Mastej K; Adamiec R Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]